Takeda in on ground floor of new US academic alliance
This article was originally published in Scrip
Although it is not providing any direct funding to the initiative at this stage, Takeda is to contribute researchers and expertise to a new early stage drug discovery initiative being set up by three prominent academic institutions in the US.
You may also be interested in...
Positive clinical results pave path forward for Japanese firm’s potential istradefylline successor.
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.